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Nicotinepoisoninghasbeenobservedinchildren
from ingestion of cigarettes, chewing gums &
tobacco.1'2 Application ofseveral patches to skin
cancauseseriousoverdosageresultinginserious
toxicity due to first pass metabolism. A case is
reported of nicotine overdose from patch
application. A brief review of presentation and
management of this condition is presented.3
INTRODUCTION
Transdermal nicotine patches (TNPs) are in use
as an efficient method of drug delivery, helping
adults to avoid cigarette smoking. We report an
interesting case, where a child out of curiosity
used these resulting in intoxication.
CASE REPORT
An 11 year old boy brought to our accident &
emergencydepartmentbyemergencyambulance.
Hedescribedfeelingnauseated, weakandunwell
during play. He walked home, vomited twice
complained of palpitation and fell to the floor
from a settee feeling weak. He remained fully
responsive. On arrival at A & E he was alert but
anxious and complained of head and stomach
acheandweakness. Onexaminationhewasunable
to stand and his skin was cold and clammy.
Breathing, circulationandlevelofconsciousness
were all norma, inparticularhe had aregularfull
volume pulse 90beats/min, BP 115/80. No
neurologicaldeficiencywasnoted. Randomblood
sugar and ECG were normal. The nicotine patch
was found applied on leftupperouter arm during
the application of ECG electrode. A patch mark
wasevidentbelowtheinsitupatch.Theyactually
belonged to mother under treatment for smoking
cessation. The first was applied the previous
night and the second midday at the day of
presentation. A diagnosis of nicotine poisoning
was made. Patches were immediately removed
and theskinwashedwithwater.Patientmonitored
in A & E Department for fourhours. During stay
BP dropped to 90/60, pulse 70beats/min. A fluid
bolus was initially administered and repeated.
Noimprovementwasnoticed. InjectionAtropine
Sulphate (.02mg/kg body weight) was
administered intramuscularly. His condition
improved gradually and he was asymptomatic
after 4 hours. He was discharged home later.
DISCUSSION
Symptoms arising from inadvertent exposure to
nicotine can be wide ranging in severity. These
depend on dose, duration of exposure and route
of administration.4
As transdermal route may cause serious toxicity
due to first pass metabolism. TNPs are available
for the treatment of smoking cessation without
prescription. Therapeuticusehasbeenassociated
with a variety of adverse effects including skin
rashes, allergic skin reactions, nausea and
vomiting, sleep disturbances, headache, chest
pain. Symptoms following oral ingestion in
children include gastrointestinal symptoms,
increased salivation, pallor, weakness, and
dizziness.5
In one series, as little as 0.2mg / kg of ingested
nicotine caused mild toxic symptoms.2
Complications such as lethargy, seizure, coma,
respiratory depression, apnoea, hypertension,
hypotension &dysrythmia are seeninsignificant
intoxication.6 In a study conducted by Woolf et
a14 at 34 United States poison centres Patients
were triaged to home observation or to the
DowneHospital, 9aPoundLane, Downpatrick, CoDown,
BT30 6JA.
Accident and Emergency Department
AA Wain FRCS, Associate Specialist
J Martin FRCS, Consultant
Correspondence to Mr Wain, 21 Glenbrae, Limetree
Avenue, Knockmore Road, Lisburn, Co Antrim BT28
2YJ.
E-mail: wain59@aol.com
©) The Ulster Medical Society, 2004.66 The Ulster Medical Journal
emergency department. For patient at home a
telephone follow upfor24hours wascarriedout.
Nochildseeninemergencydepartmenthadblood
or urine sent for nicotine levels. Nicotine dose
was calculated from the estimated time of
exposure to TNP as reported by care worker.
HigherdoseTNPsreleases 0.9mgofnicotineper
hour. Dose-response relationship was observed
in TNPs releasing higher amount of nicotine.
Children with an estimated dose of absorbed
nicotine < 0.1mg/kg were unlikely to develop
symptoms.
Recommended treatments include removal of
patch, wash with water. If patch is ingested
repeateddosesofactivatedcharcoalorally.Incase
of parasympathetic or sympathetic
overstimulation use ofatropine or phentolamine
I/M or IV to be repeated as necessary.
CONCLUSION
As TNPs7 are available without prescription as
aids forthe treatment ofsmoking cessation, they
are accessible to children. As data regarding
toxic effect on paediatric TNPs exposure is
lacking, these cases should be reported. Users
need to be educated for safekeeping.
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